New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).In its latest enforcement report, the US health regulator said that Cipla USA, Inc, based in Warren, New Jersey, is recalling certain batches of Nilotinib Capsules in two strengths — 150 mg and 200 mg.The recall involves 271 cartons of one batch and 164 cartons of another batch of the …
Trending
- Phula (2026) Movie Review: A Soulful Tale of Resilience and Folk Art
- Therachaapa Movie Review: A Rooted Rustic Drama Packed With Emotion and Grit
- Salbardi (2026) Review: A Gripping Tale of Mystery and Justice From the Heartland
- Bad Boy Karthik Review (2026): A Brother’s Fight That Packs Enough Heart to Win You Over
- Matka King Review: Vijay Varma’s Finest Hour in a Gripping Bombay Crime Drama
- Pallichattambi Movie Review: Tovino Thomas Leads a Powerful Period Drama with Mass Appeal
- Mr X Movie Review: Stylish Spy Action Thriller Delivers Big-Screen Entertainment with Arya in Command
- Thimmarajupalli TV Movie Review: A Heartwarming Nostalgia Trip That Captures the Soul of Rural Telugu Cinema